Introduction: Documenting normal hair values through trichoscopy can provide a useful baseline when evaluating and treating hair loss in different populations. The aim of our study was to document normal values for measurable parameters of hair in adult Egyptian females. Methods: This cross-sectional study involved 90 Egyptian females (age range 18–48 years), with no symptoms or signs of hair or scalp disease. Trichoscopy was performed in different scalp areas using FotoFinder Medicam 1000 videodermoscopy. Trichoscopy images were subjected to statistical processing using TrichoLAB system. Results: The frontal area demonstrated the highest number of hairs (190 ± 29/cm2), greatest average hair shaft thickness (63 ± 8 μm), greatest percentage of thick hairs (71% ± 12), highest mean cumulative hair thickness (12 ± 2 mm/cm2), and highest mean number of follicular units (82 ± 8/cm2). The temporal area showed the highest percentage of thin hairs (9% ± 5) and single-hair pilosebaceous units (23% ± 7), lowest mean number of hairs (154 ± 25/cm2), least average hair shaft thickness (60 ± 9 μm), least mean cumulative hair thickness (9 ± 2 mm/cm2), and least mean number of follicular units (70 ± 8/cm2). The occipital area showed the greatest percentage of triple-hair follicles (43% ± 12). Based on trichoscopy, the norms for hair parameters were calculated. Conclusion: Normal hair parameters in adult Egyptian females differ from those documented from other ethnicities. Evaluating and treating hair loss in clinical practice should be done in reference to documented normal values, which can be set through trichoscopy.

1.
Tosti
A
.
Tricoscopia
. In:
Camacho
F
,
Tosti
A
,
Randall
V
,
Price
VH
, editors.
Tricología. Enfermedades del folículo pilosebáceo
.
Madrid
;
2013
. p.
183
.
2.
Romero
JAM
,
Grimalt
R
.
Trichoscopy: essentials for the dermatologist
.
World J Dermatol
.
2015
;
4
(
2
):
63
. .
3.
Rakowska
A
.
Trichoscopy (hair and scalp videodermoscopy) in the healthy female. Method standardization and norms for measurable parameters
.
J Dermatol Case Rep
.
2009
;
3
(
1
):
14
9
. .
4.
Buch
JY
,
Criton
S
.
Trichoscopic findings in normal hair and scalp in children under 17 years
.
Int J Trichology
.
2019
;
11
(
5
):
189
. .
5.
Birnbaum
MR
,
McLellan
BN
,
Shapiro
JY
,
Ye
K
,
Reid
SD
.
Evaluation of hair density in different ethnicities in a healthy American Population using quantitative trichoscopic analysis
.
Skin Appendage Disord
.
2018
;
4
(
4
):
304
7
. ‏.
6.
Leerunyakul
K
,
Suchonwanit
P
.
Evaluation of hair density and hair diameter in the adult Thai Population using quantitative trichoscopic analysis
.
BioMed Res Inter
.
2020
;
2020
:
1
6
. .
7.
‏Rakowska
A
,
Slowinska
M
,
Kowalska-Oledzka
E
,
Rudnicka
L
.
Trichoscopy in genetic hair shaft abnormalities
.
J Dermatol Case Rep
.
2008
;
2
(
2
):
14
20
. .
8.
Rakowska
A
,
Slowinska
M
,
Kowalska-Oledzka
E
,
Warszawik
O
,
Czuwara
J
,
Olszewska
M
.
Trichoscopy of cicatricial alopecia
.
J Drugs Dermatol
.
2012
;
11
(
6
):
753
8
.
9.
Rakowska
A
,
Slowinska
M
,
Olszewska
M
,
Rudnicka
L
.
New trichoscopy findings in trichotillomania: flame hairs, V-sign, hook hairs, hair powder, tulip hairs
.
Acta Dermatol Venereol
.
2014
;
94
(
3
):
303
6
. .
10.
Mubki
T
,
Rudnicka
L
,
Olszewska
M
,
Shapiro
J
.
Evaluation and diagnosis of the hair loss patient: part II. Trichoscopic and laboratory evaluations
.
J Am Acad Dermatol
.
2014
;
71
(
3
):
431.e1
-
431.e11
. .
11.
Rakowska
A
,
Slowinska
M
,
Kowalska-Oledzka
E
,
Olszewska
M
,
Rudnicka
L
.
Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria
.
Int J Trichol
.
2009
;
1
(
2
):
123
. .
12.
Kibar
M
,
Aktan
S
,
Bilgin
M
.
Scalp dermatoscopic findings in androgenetic alopecia and their relations with disease severity
.
Ann Dermatol
.
2014
;
26
(
4
):
478
. .
13.
Kasprzak
M
,
Sicińska
J
,
Sinclair
R
.
The trichoscopy derived sinclair scale: enhancing visual assessment through quantitative trichoscopy
.
Australas J Dermatol
.
2019
;
60
(
2
):
134
6
. ‏ .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.